Luxembourg, September 17, 2020 – B Medical Systems, a leading European medical refrigeration and global vaccine cold chain manufacturer, is pleased to announce the official opening of its new 10,000 sq ft sales office and warehouse in Noblesville, Indiana. With over 40 years of experience in the medical refrigeration and vaccine cold chain market, the company offers a full line of medical-grade refrigerators, freezers, ultra-low temperature freezers, and transport devices designed for the safe storage and transport of biological materials, critical samples, blood, and vaccines.
“The establishment of B Medical Systems in North America [in Indiana] follows the growing expansion of our company worldwide,” said Luc Provost, CEO at B Medical Systems.
B Medical Systems’ equipment is produced to meet the most stringent standards of quality. Certified by the US FDA, the EU MDR, and the WHO PQS, they are consistently reliable devices tailored to the critical needs of blood banks, hospitals, research institutes, and the life sciences industry globally.
Since 1979, B Medical Systems has grown into a global player recognized for the quality of its products and services. Today, over 130 countries rely on its technology.
“The United States represents an undeniable share of the medical device market in the world. We believe that the energy-efficiency and sustainability benefits of our products will provide a competitive edge in the American market. This centrally located facility [in Indiana] allows timely delivery throughout the US,” commented Matin Khajooei, Chief Sales & Marketing Officer at B Medical Systems.
Critical moment in history
As the world is battling against the coronavirus, B Medical Systems has been putting its experience and network to work in an effort to be a strong partner in the global fight.
“In the last quarter, we observed a surge in the demand for our refrigerators, freezers, and cold boxes to store medications, transport test specimens, and process convalescent plasma,” Mr. Khajooei said.
B Medical Systems has also been preparing to support the expedited and efficient distribution of the vaccines.
“When the COVID-19 vaccine is proven safe and effective, the need for reliable cold chain systems will be more critical than ever. As leader in the vaccine cold chain industry for the last 4 decades, we have a role to play,” Mr. Provost concluded.